264
Views
44
CrossRef citations to date
0
Altmetric
Review

New developments in the management of head and neck cancer – impact of pembrolizumab

, , , &
Pages 295-303 | Published online: 19 Feb 2018

Figures & data

Table 1 Main studies of immune checkpoint inhibitors in HNSCC

Table 2 Ongoing trials of pembrolizumab